[Preliminary clinical study of fubiding in treatment of perennial allergic rhinitis].
OBJECTIVE
To observe therapeutic effect and adverse reaction of Fubiding (Desloratadine tablets) in treatment of perennial allergic rhinitis (PAR).


METHODS
One hundred and fifty PAR patients were confer five milligram Fubiding everyday by mouth, in series 30 days. To detain to use etc's allergic medicine or naristillae.


RESULTS
All cases were visited a year, the 109 examples of show were excellence (72.67%), 34 cases were effectively (22.67%), 7 examples were nullity (4.67%). The gross is efficient to attain 95.34%. And the adverse effects were slightly.


CONCLUSIONS
Fubiding in treatment PAR has the curative effect shows excellence, the adverse effects were slightly etc. advantage. The worthy of clinical expansion is applied.
Li
Xushu
X
Department of Otorhinolaryngology, Longhu People's Hospital, Shantou, 515041, China. Lixushu@haoyisheng.com.cn
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D039563:Histamine H1 Antagonists, Non-Sedating / Q000627:therapeutic use*; D006801:Humans; D017336:Loratadine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy*
D039563:Histamine H1 Antagonists, Non-Sedating; D017336:Loratadine; C121345:desloratadine